Public procurement notice: Contract Award Notice
Published: 2025-06-11
Buyer: Amgros I/S
Country: DK
Region: DK011
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 11765767 EUR
Submission deadline: 2029-03-31
Award criteria: price

Technical requirements: Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.
Price is not the only award criterion and all criteria are stated only in the procurement documents.
Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no. 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints: Complaints of the tendering procedure must be lodged with the Complaints Board for Public Procurement within 6 months after the contracting entity has entered into a framework agreement calculated from the day after the day when the contracting entity has notified the affected applicants and tenderers, see section 7(2), para.(3) of the Act. Not later than at the time of lodging a complaint with the Danish Complaints Board for Public Procurement, the complainant must notify the contracting authorities in writing that a complaint has been lodged with the Danish Complaints Board for Public Procurement and whether the complaint was lodged during the standstill period, see section 6(4) of the Act. In cases where the complaint was not lodged within the standstill period, the complainant must furthermore indicate whether a suspensory effect of the complaint has been requested, see clause 6(4) of the Act.
ATC Code: J01DH02,
Generic Name: Meropenem, 
Pharmaceutical form: Injection and Infusion Fluid,
Strength: 500 mg,
Pack size: Vial,
Unit: 3 g,
Quantity in units: Denmark: 5.578, Iceland: 433, Norway: 2.000.
ATC Code: J01DH02,
Generic Name: Meropenem, 
Pharmaceutical form: Injection and Infusion Fluid,
Strength: 1000 mg,
Pack size: Vial,
Unit: 3 g,
Quantity in units: Denmark: 176.842, Iceland: 11.000, Norway: 60.000.
Under the title "Quantity in units", an estimated consumption of the pharmaceuticals is indicated for each of the countries. It should be noted that this estimate corresponds to the historical consumption of the pharmaceuticals put up for tender and that suppliers must expect that the actual purchase under a framework agreement may deviate significantly from the estimate. Reference is made to paragraph 5.6 of the tender specifications and clause 4.2 in the framework agreement.
The Contracting Authorities shall be entitled to extend the framework agreement up to two times for each pharmaceutical on unchanged terms and conditions by up to 12 months. See Framework Agreement section 8.2.


Winner: FrostPharma AB
Award value: 3256789
Number of bids: 3